Showing results (11-20 of 777) with videos related to

Sort By:
Pageof 78
In Silico Pharmacology|August 5, 2021
Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug designOlusola Olalekan Elekofehinti, Opeyemi Iwaloye, Femi Olawale, et al.
In Silico Pharmacology|August 2, 2021
In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid proteinRitu Bansal, Sanika Mohagaonkar, Anamitra Sen, et al.
In Silico Pharmacology|September 5, 2022
Formulation and in-silico study of meclizine ointment as anti-eczemaWafa M Al-Madhagi, Abdulkarim K Y Alzomor, Nor Hisam Zamakshshari, et al.
In Silico Pharmacology|March 8, 2021
Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico studyFateme Sefid, Zahra Payandeh, Ghasem Azamirad, et al.
In Silico Pharmacology|September 8, 2022
Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studiesSantosh Kumar Maurya, Homa Fatma, Akhilesh Kumar Maurya, et al.
In Silico Pharmacology|January 9, 2025
In silico design and computational screening of berberine derivatives for potential antidiabetic activity through allosteric activation of the AMPK pathwayBibhuti Bhusan Kakoti, James H Zothantluanga, Kangkan Deka, et al.
Pageof 78